RNA, U6 small nuclear 505, pseudogene (RNU6-505P)

RNA, U6 small nuclear 505, pseudogene (RNU6-505P) is a non-coding RNA pseudogene, derived from U6 small nuclear RNA (snRNA)[1]. Unlike functional U6 snRNA, which is a well-characterized component of the spliceosome essential for pre-mRNA splicing[5], RNU6-505P does not code for a functional RNA product and is classified as a pseudogene. Although pseudogenes were formerly considered non-functional, emerging evidence shows that some can be transcribed and have regulatory roles, such as generating small interfering RNAs or acting as microRNA decoys, thereby influencing gene expression[6]. For RNU6-505P in particular, ontological and microarray studies suggest it is differentially expressed in brain tissue and may be involved in brain development and neuropsychiatric conditions, including schizophrenia[2]. However, its precise molecular mechanism, function, and direct interaction with drugs remain uncharacterized. RNU6-505P is not classified as a therapeutic target (e.g., receptor, enzyme, transporter). No interacting drugs, direct mechanisms of drug action, or specific safety issues have been identified for this pseudogene. It is currently of interest primarily as a potential biomarker for neurological disorders, particularly if future studies further confirm its diagnostic utility[2].

Other names

RNU6-505PU6 small nuclear RNA pseudogene 505